| |
| |
|
| Insider
Information: |
Goyal Vikas |
| Relationship: |
See Remarks |
| City: |
Conshohocken |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
1,000 |
|
|
Indirect Shares
|
4,487,778 |
|
|
| Direct
Value |
$29,900 |
|
|
|
Indirect Value
|
$81,771,813 |
|
|
| Total
Shares |
4,488,778 |
|
|
| Total
Value |
$81,801,713 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -24.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Spero Therapeutics Inc |
SPRO |
Director |
2017-11-06 |
0 |
2017-11-06 |
1,854,006 |
Premium* |
|
|
Morphic Holding, Inc. |
MORF |
Director |
2021-03-05 |
1,000 |
2019-07-01 |
2,633,772 |
Premium* |
|
|
Pandion Therapeutics, Inc. |
PAND |
See Remarks |
2021-04-01 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PAND |
Pandion Therapeutics, Inc... |
See Remarks |
• – – |
2021-04-01 |
4 |
D |
$60.00 |
$5,265,840 |
D/D |
(87,764) |
0 |
0 |
- |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2021-03-05 |
4 |
B |
$70.00 |
$70,000 |
D/D |
1,000 |
1,000 |
2.39 |
% |
|
| PAND |
Pandion Therapeutics, Inc... |
See Remarks |
• – – |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
7,044 |
86,314 |
0 |
- |
|
| PAND |
Pandion Therapeutics, Inc... |
See Remarks |
• – – |
2020-07-21 |
4 |
B |
$18.00 |
$26,100 |
D/D |
1,450 |
87,764 |
2.74 |
- |
|
| PAND |
Pandion Therapeutics, Inc... |
See RemarksOfficer |
• – – |
2020-07-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
79,270 |
|
- |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2019-07-01 |
4 |
A |
$0.00 |
$0 |
I/I |
2,300,439 |
2,300,439 |
0 |
- |
|
| MORF |
Morphic Holding, Inc. |
Director |
– • – |
2019-07-01 |
4 |
B |
$15.00 |
$4,999,995 |
I/I |
333,333 |
2,633,772 |
2.1 |
- |
|
| SPRO |
Spero Therapeutics Inc |
Director |
– • – |
2017-11-06 |
4 |
A |
$0.00 |
$0 |
I/I |
1,425,435 |
1,425,435 |
0 |
- |
|
| SPRO |
Spero Therapeutics Inc |
Director |
– • – |
2017-11-06 |
4 |
B |
$14.00 |
$5,999,994 |
I/I |
428,571 |
1,854,006 |
2.1 |
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
